NCI Data Jamboree (Project Abstract Submission): Submission #63
Submission information
Submission Number: 63
Submission ID: 189204
Submission UUID: 4fd1609c-23fa-4a00-9667-2f0c7120520e
Submission URI: /nci/datajamboree/abstractsubmission
Submission Update: /nci/datajamboree/abstractsubmission?token=u7F9UFrwy93mq3dP4zAAKkotRM5qTz-HNZeytgJ05mk
Created: Mon, 07/27/2026 - 23:11
Completed: Mon, 07/27/2026 - 23:11
Changed: Mon, 07/27/2026 - 23:11
Remote IP address: 10.208.24.192
Submitted by: Anonymous
Language: English
Is draft: No
Webform: NCI Data Jamboree (Abstracts)
Submitted to: NCI Data Jamboree (Project Abstract Submission)
Presenter Information
---------------------
First Name: Avani
Middle Initial: {Empty}
Last Name: Patel
Degree(s): N.A.
Position/Title/Career Status: {Empty}
Organization: Animal Genome Institute
Organization Address:
Palmyra
Email: info@animalgenomeinstitute.org
Additional Authors
------------------
List of Additional Authors:
- First Name: Yuka
Last Name: Imamura
Affiliation: Animal Genome Institute
Abstract Information
--------------------
Abstract Category: Employing statistical, computational, and informatics tools, algorithms, and methods to integrate or analyze data
Abstract Keywords: {Empty}
Abstract Title: Cross-Species Signature Scoring and Risk Assessment Modeling for Human and Canine Osteosarcoma
Abstract:
Osteosarcoma is a genetically complex malignancy. While human and canine osteosarcomas share significant molecular similarities, integrating datasets across species and sequencing platforms remains a technical challenge. Overcoming these hurdles is crucial for identifying conserved oncological targets and improving the AI-readiness of comparative genomic data for the broader research community. We aim to develop and validate a robust computational framework for cross-species data integration, specifically focusing on continuous signature scoring models for human and canine osteosarcoma. By utilizing publicly available human osteosarcoma datasets (such as TARGET-OS) and public canine cohorts (such as NCI's DOG² cohort), we will employ expression data scaling techniques, cross-platform normalization, and continuous signature scoring algorithms to harmonize the disparate matrices. Ultimately, we aim to leverage these validated models to develop a cross-species risk assessment application to support clinical decision-making.